milvexian
bms
['axiomatic', 'fxi', 'milvexian']
oral fxia inhibitor milvexian did not increase bleeding events when added to antiplatelet therapy after acute stroke, results from the phase 2 axiomatic-ssp trial: summary and analysis by 